February 2, 2017 / 12:34 PM / in a year

BRIEF-Trillium therapeutics says to provide update TTI-621 trials by year-end

Feb 2 (Reuters) - Trillium Therapeutics Inc

* Says intends to provide an update on ongoing TTI-621 trials by year-end

* Says in 2017 trillium intends to continue investigating Sirpafc in relevant preclinical models

* Says during the year, it expects to make progress in phase 1b tti-621-01 study

* Trillium therapeutics says in second phase 1 trial on tti-621-02 expects to complete dose escalation phase and potentially begin an expansion phase in 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below